REPORTS

Let’s Pullulate and Expand Your Business

Valsartan Drug Market - Global Professional Analysis and Forecast to 2026

Feb 19, 2020  |  167 PAGES  |  REPORT CODE: CMM267680
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Valsartan Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.1% during the forecast period.

This report presents the market size and development trends by detailing the Valsartan Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Valsartan Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Valsartan Drug industry and will help you to build a panoramic view of the industrial development.

Valsartan Drug Market, By Type:

  • 40 mg Tablets

  • 80 mg Tablets

  • 160 mg Tablets

  • 320 mg Tablets

Valsartan Drug Market, By Application:

  • Hypertension

  • Heart Failure

  • Heart Attack

Some of the leading players are as follows:

  • Unichem Laboratories

  • Jubilant Pharma

  • Amneal Pharmaceuticals

  • Sun Pharmaceutical

  • Torrent Pharmaceuticals

  • Zhejiang Huahai Pharmaceutical

  • Mylan

  • Square Pharmaceuticals

  • Novartis

  • Lupin

  • Macleods Pharmaceuticals

  • HETERO

  • Alembic Pharmaceuticals

  • Huaren Pharmaceutical

  • Teva

  • Aurobindo Pharma

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Valsartan Drug Market: Technology Type Analysis

  • 4.1 Valsartan Drug Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Valsartan Drug Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 40 mg Tablets

    • 4.3.2 80 mg Tablets

    • 4.3.3 160 mg Tablets

    • 4.3.4 320 mg Tablets

5 Valsartan Drug Market: Product Analysis

  • 5.1 Valsartan Drug Product Market Share Analysis, 2018 & 2026

  • 5.2 Valsartan Drug Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Valsartan Drug Market: Application Analysis

  • 6.1 Valsartan Drug Application Market Share Analysis, 2018 & 2026

  • 6.2 Valsartan Drug Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hypertension

    • 6.3.2 Heart Failure

    • 6.3.3 Heart Attack

7 Valsartan Drug Market: Regional Analysis

  • 7.1 Valsartan Drug Regional Market Share Analysis, 2018 & 2026

  • 7.2 Valsartan Drug Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Unichem Laboratories

    • 9.1.1 Unichem Laboratories Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Jubilant Pharma

    • 9.2.1 Jubilant Pharma Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Amneal Pharmaceuticals

    • 9.3.1 Amneal Pharmaceuticals Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Sun Pharmaceutical

    • 9.4.1 Sun Pharmaceutical Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Torrent Pharmaceuticals

    • 9.5.1 Torrent Pharmaceuticals Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Zhejiang Huahai Pharmaceutical

    • 9.6.1 Zhejiang Huahai Pharmaceutical Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Mylan

    • 9.7.1 Mylan Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Square Pharmaceuticals

    • 9.8.1 Square Pharmaceuticals Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Novartis

    • 9.9.1 Novartis Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Lupin

    • 9.10.1 Lupin Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Macleods Pharmaceuticals

    • 9.11.1 Macleods Pharmaceuticals Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 HETERO

    • 9.12.1 HETERO Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Alembic Pharmaceuticals

    • 9.13.1 Alembic Pharmaceuticals Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Huaren Pharmaceutical

    • 9.14.1 Huaren Pharmaceutical Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Teva

    • 9.15.1 Teva Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Aurobindo Pharma

    • 9.16.1 Aurobindo Pharma Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

 

The List of Tables and Figures (Totals 113 Figures and 149 Tables)

  • Figure 40 mg Tablets Valsartan Drug market, 2015 - 2026 (USD Million)

  • Figure 80 mg Tablets Valsartan Drug market, 2015 - 2026 (USD Million)

  • Figure 160 mg Tablets Valsartan Drug market, 2015 - 2026 (USD Million)

  • Figure 320 mg Tablets Valsartan Drug market, 2015 - 2026 (USD Million)

  • Figure Hypertension market, 2015 - 2026 (USD Million)

  • Figure Heart Failure market, 2015 - 2026 (USD Million)

  • Figure Heart Attack market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Valsartan Drug market, by country, 2015 - 2026 (USD Million)

  • Table North America Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table North America Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table North America Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Canada Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Canada Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Europe Valsartan Drug market, by country, 2015 - 2026 (USD Million)

  • Table Europe Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Europe Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Europe Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Germany Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Germany Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table France Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table France Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Italy Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Italy Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Spain Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Spain Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Valsartan Drug market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table China Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table China Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Japan Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Japan Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table India Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table India Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Valsartan Drug market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table MEA Valsartan Drug market, by country, 2015 - 2026 (USD Million)

  • Table MEA Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table MEA Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table MEA Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Valsartan Drug market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Valsartan Drug market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Valsartan Drug market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Unichem Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Jubilant Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amneal Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sun Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Torrent Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zhejiang Huahai Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Square Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lupin Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Macleods Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table HETERO Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Alembic Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Huaren Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aurobindo Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top